Quantum Uncertainty Limit for Stern-Gerlach Interferometry with Massive Objects
Physical Review Letters · 16.03.2023 · 130 (11)
DOI: 10.1103/physrevlett.130.113602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review Letters, online erschienen am 16.03.2023. Verfasst von Yonathan Japha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Ben-Gurion University of the Negev, Be'er Sheva 84105, Israel. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
We analyze the fundamental coherence limit of a nano-object with an embedded spin in a Stern-Gerlach interferometer. This limit stems from the which-path information provided by the object's rotational degrees of freedom due to the evolution of their quantum uncertainty. We show that such interferometry is straightforward in a weak magnetic field and short duration. Large wave packet separation is made possible with proper fine-tuning over long durations. This opens the door to fundamental tests of quantum theory and quantum gravity. The results and conclusions are extendable to any type of interferometry with complex objects.
Autor:innen und Institutionen
- Department of Physics, Ben-Gurion University of the Negev, Be'er Sheva 84105, Israel.
Förderung
- Israel Science Foundation
Zitieren
APA
Japha, Y., & Folman, R. (2023). Quantum Uncertainty Limit for Stern-Gerlach Interferometry with Massive Objects. Physical Review Letters, 130(11). https://doi.org/10.1103/physrevlett.130.113602
Vancouver
Japha Y, Folman R. Quantum Uncertainty Limit for Stern-Gerlach Interferometry with Massive Objects. Physical Review Letters. 2023;130(11). doi:10.1103/physrevlett.130.113602
BibTeX
@article{Japha2023,
author = {Japha, Yonathan and Folman, Ron},
title = {Quantum Uncertainty Limit for Stern-Gerlach Interferometry with Massive Objects},
journal = {Physical Review Letters},
year = {2023},
volume = {130},
number = {11},
doi = {10.1103/physrevlett.130.113602}
}
EUVIMED